Literature DB >> 26344707

A quarter century of progress in paediatric clinical pharmacology: A personal view.

Stuart M MacLeod1,2.   

Abstract

Keywords:  child health; clinical pharmacology; medicines; pediatrics; progress

Mesh：

Year:  2015        PMID： 26344707      PMCID： PMC4833166          DOI： 10.1111/bcp.12776

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  37 in total

Review 1.  Drug therapy for breast-feeding women.

Authors:  S Ito
Journal:  N Engl J Med       Date:  2000-07-13       Impact factor: 91.245

2.  Pediatric pharmacology in Japan.

Authors:  Shinya Ito; Hidefumi Nakamura; Tohru Kobayashi
Journal:  Paediatr Drugs       Date:  2012-08-01       Impact factor: 3.022

Review 3.  Gene therapy for mucopolysaccharidosis.

Authors:  Katherine P Ponder; Mark E Haskins
Journal:  Expert Opin Biol Ther       Date:  2007-09       Impact factor: 4.388

4.  Better medicines for 300 million children in China: report on recent progress.

Authors:  Zhiping Li; Li Wang; Yi Wang; Yonghao H Gui; Alexander A Vinks; Stuart MacLeod
Journal:  Paediatr Drugs       Date:  2011-06-01       Impact factor: 3.022

5.  The study of drugs for rare disorders: harnessing research contributions by Canadian academic institutions.

Authors:  Stuart Macleod; Paul Lasko; Alex Mackenzie
Journal:  J Popul Ther Clin Pharmacol       Date:  2014-02-23

6.  Home-fortification with iron and zinc sprinkles or iron sprinkles alone successfully treats anemia in infants and young children.

Authors:  Stanley Zlotkin; Paul Arthur; Claudia Schauer; Kojo Yeboah Antwi; George Yeung; Ana Piekarz
Journal:  J Nutr       Date:  2003-04       Impact factor: 4.798

7.  Therapeutic orphans.

Authors:  H Shirkey
Journal:  J Pediatr       Date:  1968-01       Impact factor: 4.406

8.  Clinical pharmacology scope, organization, training. Report of a WHO study group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1970

9.  Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease.

Authors:  P S Kishnani; D Corzo; M Nicolino; B Byrne; H Mandel; W L Hwu; N Leslie; J Levine; C Spencer; M McDonald; J Li; J Dumontier; M Halberthal; Y H Chien; R Hopkin; S Vijayaraghavan; D Gruskin; D Bartholomew; A van der Ploeg; J P Clancy; R Parini; G Morin; M Beck; G S De la Gastine; M Jokic; B Thurberg; S Richards; D Bali; M Davison; M A Worden; Y T Chen; J E Wraith
Journal:  Neurology       Date:  2006-12-06       Impact factor: 9.910

10.  Ivacaftor: the first therapy acting on the primary cause of cystic fibrosis.

Authors:  G L McPhail; J P Clancy
Journal:  Drugs Today (Barc)       Date:  2013-04       Impact factor: 2.245
View more
  2 in total

1.  A quarter century of progress in paediatric clinical pharmacology: A personal view.

Authors:  Stuart M MacLeod
Journal:  Br J Clin Pharmacol       Date:  2015-11-10       Impact factor: 4.335

2.  Key Challenges in the Search for Innovative Drug Treatments for Special Populations. Converging Needs in Neonatology, Pediatrics, and Medical Genetics.

Authors:  Stuart MacLeod
Journal:  Children (Basel)       Date:  2017-08-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.